A GENETIC ASSOCIATION BETWEEN JUVENILE RHEUMATOID-ARTHRITIS AND A NOVEL INTERLEUKIN-1-ALPHA POLYMORPHISM

被引:299
作者
MCDOWELL, TL
SYMONS, JA
PLOSKI, R
FORRE, O
DUFF, GW
机构
[1] UNIV SHEFFIELD,ROYAL HALLAMSHIRE HOSP,SHEFFIELD S10 2JF,S YORKSHIRE,ENGLAND
[2] NATL HOSP NORWAY,OSLO,NORWAY
[3] SANITETFORENINGS RHEUMAT HOSP,OSLO,NORWAY
来源
ARTHRITIS AND RHEUMATISM | 1995年 / 38卷 / 02期
关键词
D O I
10.1002/art.1780380210
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. The genetic factors that predispose to the development of juvenile rheumatoid arthritis (JRA) and its complications are not completely understood. The cytokine interleukin-1 (IL-1) has been implicated in the pathogenesis of JRA and other inflammatory diseases. This study was performed to test whether polymorphisms of the IL-1 alpha gene might be associated with JRA. Methods. We sequenced the 5' regulatory region (containing the promoter) of the human IL-1 alpha gene in 18 normal subjects. This revealed a C (IL-1A1) to T (IL-1A2) transition polymorphism at position -889. We studied the frequencies of both alleles in patients with JRA (n = 269) and controls (n = 99). Results. An increased gene carriage of IL-1A2 was found in patients with early-onset, pauciarticular JRA (EOPA-JRA; n = 103) compared with controls (0.66 versus 0.49; P = 0.01, odds ratio [OR] = 2.1). Within this subset of JRA, the association with IL-1A2 was particularly strong in the patients in whom chronic iridocyclitis developed (n = 28) compared with those without chronic iridocyclitis (0.89 versus 0.57; P = 0.002, OR = 6.2). Within the group of EOPA-JRA patients, IL-1A2 was also associated with elevation of the erythrocyte sedimentation rate (P < 0.0025). Conclusion. This is the first report of a cytokine gene association with JRA, and we conclude that IL-1 alpha itself, or a gene for which the IL-1 alpha polymorphism is a marker, may contribute to the pathogenesis of EOPA-JRA and the ocular complications found in this group.
引用
收藏
页码:221 / 228
页数:8
相关论文
共 53 条
[1]   DIAGNOSIS OF PROBABLE STILLS DISEASE AND ITS OUTCOME [J].
ANSELL, BM ;
BYWATERS, EG .
ANNALS OF THE RHEUMATIC DISEASES, 1962, 21 (03) :253-&
[2]   GENETIC-POLYMORPHISM OF HUMAN INTERLEUKIN-1-ALPHA [J].
BAILLY, S ;
DIGIOVINE, FS ;
BLAKEMORE, AIF ;
DUFF, GW .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (06) :1240-1245
[3]  
BARRON KS, 1993, ARTHRITIS RHEUM, V36, pS82
[4]   INTERLEUKIN-1 RECEPTOR ANTAGONIST GENE POLYMORPHISM AS A DISEASE SEVERITY FACTOR IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
BLAKEMORE, AIF ;
TARLOW, JK ;
CORK, MJ ;
GORDON, C ;
EMERY, P ;
DUFF, GW .
ARTHRITIS AND RHEUMATISM, 1994, 37 (09) :1380-1385
[5]  
Brewer E J Jr, 1977, Arthritis Rheum, V20, P195
[6]  
CASSIDY JT, 1988, J RHEUMATOL, V15, P535
[7]  
CLAY FE, 1994, HUM GENET, V94, P407
[8]   CHROMOSOMAL LOCATION OF MURINE AND HUMAN IL-1 RECEPTOR GENES [J].
COPELAND, NG ;
SILAN, CM ;
KINGSLEY, DM ;
JENKINS, NA ;
CANNIZZARO, LA ;
CROCE, CM ;
HUEBNER, K ;
SIMS, JE .
GENOMICS, 1991, 9 (01) :44-50
[9]  
DAVID J, 1990, Arthritis and Rheumatism, V33, pS118
[10]   HUMAN RECOMBINANT INTERLEUKIN-1 STIMULATES COLLAGENASE AND PROSTAGLANDIN E-2 PRODUCTION BY HUMAN SYNOVIAL-CELLS [J].
DAYER, JM ;
DEROCHEMONTEIX, B ;
BURRUS, B ;
DEMCZUK, S ;
DINARELLO, CA .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (02) :645-648